214 related articles for article (PubMed ID: 21300830)
1. Penetration of meropenem into epithelial lining fluid of patients with ventilator-associated pneumonia.
Lodise TP; Sorgel F; Melnick D; Mason B; Kinzig M; Drusano GL
Antimicrob Agents Chemother; 2011 Apr; 55(4):1606-10. PubMed ID: 21300830
[TBL] [Abstract][Full Text] [Related]
2. Telavancin penetration into human epithelial lining fluid determined by population pharmacokinetic modeling and Monte Carlo simulation.
Lodise TP; Gotfried M; Barriere S; Drusano GL
Antimicrob Agents Chemother; 2008 Jul; 52(7):2300-4. PubMed ID: 18426898
[TBL] [Abstract][Full Text] [Related]
3. Penetration of vancomycin into epithelial lining fluid in healthy volunteers.
Lodise TP; Drusano GL; Butterfield JM; Scoville J; Gotfried M; Rodvold KA
Antimicrob Agents Chemother; 2011 Dec; 55(12):5507-11. PubMed ID: 21911567
[TBL] [Abstract][Full Text] [Related]
4. Meropenem penetration into epithelial lining fluid in mice and humans and delineation of exposure targets.
Drusano GL; Lodise TP; Melnick D; Liu W; Oliver A; Mena A; VanScoy B; Louie A
Antimicrob Agents Chemother; 2011 Jul; 55(7):3406-12. PubMed ID: 21576431
[TBL] [Abstract][Full Text] [Related]
5. Is One Sample Enough? β-Lactam Target Attainment and Penetration into Epithelial Lining Fluid Based on Multiple Bronchoalveolar Lavage Sampling Time Points in a Swine Pneumonia Model.
Motos A; Kuti JL; Li Bassi G; Torres A; Nicolau DP
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509937
[TBL] [Abstract][Full Text] [Related]
6. Impact of meropenem in combination with tobramycin in a murine model of Pseudomonas aeruginosa pneumonia.
Louie A; Liu W; Fikes S; Brown D; Drusano GL
Antimicrob Agents Chemother; 2013 Jun; 57(6):2788-92. PubMed ID: 23571540
[TBL] [Abstract][Full Text] [Related]
7. Determination of meropenem penetration into the lung from Sparse data.
Kees MG; Lodise TP; Drusano GL
Antimicrob Agents Chemother; 2011 Dec; 55(12):5959-61. PubMed ID: 22081725
[No Abstract] [Full Text] [Related]
8. Pharmacodynamics of levofloxacin in a murine pneumonia model of Pseudomonas aeruginosa infection: determination of epithelial lining fluid targets.
Louie A; Fregeau C; Liu W; Kulawy R; Drusano GL
Antimicrob Agents Chemother; 2009 Aug; 53(8):3325-30. PubMed ID: 19364849
[TBL] [Abstract][Full Text] [Related]
9. Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial.
Benítez-Cano A; Luque S; Sorlí L; Carazo J; Ramos I; Campillo N; Curull V; Sánchez-Font A; Vilaplana C; Horcajada JP; Adalia R; Bermejo S; Samsó E; Hope W; Grau S
Crit Care; 2020 Feb; 24(1):55. PubMed ID: 32066497
[TBL] [Abstract][Full Text] [Related]
10. Modelled target attainment after meropenem infusion in patients with severe nosocomial pneumonia: the PROMESSE study.
Frippiat F; Musuamba FT; Seidel L; Albert A; Denooz R; Charlier C; Van Bambeke F; Wallemacq P; Descy J; Lambermont B; Layios N; Damas P; Moutschen M
J Antimicrob Chemother; 2015 Jan; 70(1):207-16. PubMed ID: 25216821
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics of ceftazidime and meropenem in cerebrospinal fluid: results of population pharmacokinetic modelling and Monte Carlo simulation.
Lodise TP; Nau R; Kinzig M; Drusano GL; Jones RN; Sörgel F
J Antimicrob Chemother; 2007 Nov; 60(5):1038-44. PubMed ID: 17785282
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamics of meropenem in critically ill patients with ventilator-associated pneumonia.
Jaruratanasirikul S; Kositpantawong N; Jullangkoon M; Aeinlang N; Wongpoowarak W
J Med Assoc Thai; 2013 Oct; 96(10):1283-9. PubMed ID: 24350408
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Epithelial Lining Fluid Concentration of Amikacin in Critically Ill Patients With Ventilator-Associated Pneumonia.
Najmeddin F; Shahrami B; Azadbakht S; Dianatkhah M; Rouini MR; Najafi A; Ahmadi A; Sharifnia H; Mojtahedzadeh M
J Intensive Care Med; 2020 Apr; 35(4):400-404. PubMed ID: 29471721
[TBL] [Abstract][Full Text] [Related]
14. Synergistic Meropenem-Tobramycin Combination Dosage Regimens against Clinical Hypermutable Pseudomonas aeruginosa at Simulated Epithelial Lining Fluid Concentrations in a Dynamic Biofilm Model.
Bilal H; Bergen PJ; Kim TH; Chung SE; Peleg AY; Oliver A; Nation RL; Landersdorfer CB
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427301
[TBL] [Abstract][Full Text] [Related]
15. Intrapulmonary pharmacokinetics of antibiotics used to treat nosocomial pneumonia caused by Gram-negative bacilli: A systematic review.
Heffernan AJ; Sime FB; Lipman J; Dhanani J; Andrews K; Ellwood D; Grimwood K; Roberts JA
Int J Antimicrob Agents; 2019 Mar; 53(3):234-245. PubMed ID: 30472292
[TBL] [Abstract][Full Text] [Related]
16. Imipenem, meropenem, or doripenem to treat patients with Pseudomonas aeruginosa ventilator-associated pneumonia.
Luyt CE; Aubry A; Lu Q; Micaelo M; Bréchot N; Brossier F; Brisson H; Rouby JJ; Trouillet JL; Combes A; Jarlier V; Chastre J
Antimicrob Agents Chemother; 2014; 58(3):1372-80. PubMed ID: 24342638
[TBL] [Abstract][Full Text] [Related]
17. Population Pharmacokinetics and Target Attainment of Meropenem in Plasma and Tissue of Morbidly Obese Patients after Laparoscopic Intraperitoneal Surgery.
Wittau M; Scheele J; Kurlbaum M; Brockschmidt C; Wolf AM; Hemper E; Henne-Bruns D; Bulitta JB
Antimicrob Agents Chemother; 2015 Oct; 59(10):6241-7. PubMed ID: 26248353
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacokinetics of meropenem and biapenem in bile and dosing considerations for biliary tract infections based on site-specific pharmacodynamic target attainment.
Ikawa K; Nakashima A; Morikawa N; Ikeda K; Murakami Y; Ohge H; Derendorf H; Sueda T
Antimicrob Agents Chemother; 2011 Dec; 55(12):5609-15. PubMed ID: 21947393
[TBL] [Abstract][Full Text] [Related]
19. Intrapulmonary pharmacokinetics of high doses of tigecycline in patients with ventilator-associated pneumonia.
Dimopoulos G; Almyroudi MP; Kapralos I; Apostolopoulou O; Flevari A; Nicolau DP; Dokoumetzidis A
Int J Antimicrob Agents; 2022 Jan; 59(1):106487. PubMed ID: 34843925
[TBL] [Abstract][Full Text] [Related]
20. Identifying exposure targets for treatment of staphylococcal pneumonia with ceftobiprole.
Rodvold KA; Nicolau DP; Lodise TP; Khashab M; Noel GJ; Kahn JB; Gotfried M; Murray SA; Nicholson S; Laohavaleeson S; Tessier PR; Drusano GL
Antimicrob Agents Chemother; 2009 Aug; 53(8):3294-301. PubMed ID: 19451287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
